Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

• Status: Unknown status
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study is designed to investigate the effect of postoperative adjuvant chemotherapy in prevention of tumor recurrence and metastasis for hepatocellular carcinoma after liver transplantation.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Jiao Tong University School of Medicine
• Collaborator: Shanghai Changzheng Hospital
• Treatments: Cisplatin; Doxorubicin; Gemcitabine; Liposomal doxorubicin; Oxaliplatin

Criteria

Inclusion Criteria:

• All liver transplantation patients with hepatocellular carcinoma between Dec 2008 and May 2010 are potentially eligible for enrollment.

Exclusion Criteria:

• Age less than 18 years

• Treatment with other postoperative adjuvant chemotherapy

• Survival is less than 3 months after liver transplantation

• Inability to provide written informed consent prior to study entry